Scientists map immune defenses in ovarian cancer
NCT ID NCT05984875
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the immune system in women with a new diagnosis of epithelial ovarian cancer. Researchers will collect tumor tissue, blood, and other samples to see how different immune cells relate to how long patients stay cancer-free. The goal is to learn more, not to test a new treatment. About 74 women will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPITHELIAL OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Oncology Institute of Southern Switzerland
RECRUITINGBellinzona, 6500, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••